Focused Ultrasound for Parkinson’s Disease

admin
February 28, 2026

This eBook from Blue Heron Health News

Back in the spring of 2008, Christian Goodman put together a group of like-minded people – natural researchers who want to help humanity gain optimum health with the help of cures that nature has provided. He gathered people who already know much about natural medicine and setup blueheronhealthnews.com.

Today, Blue Heron Health News provides a variety of remedies for different kinds of illnesses. All of their remedies are natural and safe, so they can be used by anyone regardless of their health condition. Countless articles and eBooks are available on their website from Christian himself and other natural health enthusiasts, such as Julissa Clay , Shelly Manning , Jodi Knapp and Scott Davis.

The Parkinson’s Protocol By Jodi Knapp Parkinson’s disease cannot be eliminated completely but its symptoms can be reduced, damages can be repaired and its progression can be delayed considerably by using various simple and natural things. In this eBook, a natural program to treat Parkinson’s disease is provided online. it includes 12 easy steps to repair your body and reduce the symptoms of this disease.

Focused Ultrasound for Parkinson’s Disease

Parkinson’s disease (PD) is one of the most common neurodegenerative disorders, affecting millions of people worldwide. It is characterized by motor symptoms such as tremor, rigidity, bradykinesia, and postural instability, as well as non-motor symptoms including depression, cognitive decline, autonomic dysfunction, and sleep disturbances. The disease results primarily from the progressive loss of dopaminergic neurons in the substantia nigra, leading to dopamine deficiency in the basal ganglia circuitry.

Although pharmacological therapies such as levodopa and dopamine agonists are highly effective in the early stages of PD, many patients eventually develop treatment-related complications including motor fluctuations and dyskinesias. When oral medications no longer provide adequate control, advanced therapies such as deep brain stimulation (DBS) or lesioning procedures may be considered.

In recent years, Magnetic Resonance-guided Focused Ultrasound (MRgFUS) has emerged as a novel, non-invasive neurosurgical technique with significant potential in the treatment of Parkinson’s disease. Unlike traditional brain surgery, which requires incisions and electrode implantation, focused ultrasound allows precise ablation of targeted brain regions without opening the skull. This essay explores the principles, mechanisms, clinical applications, efficacy, advantages, limitations, and future perspectives of focused ultrasound in Parkinson’s disease.

1. Principles of Focused Ultrasound

Focused ultrasound uses multiple beams of high-frequency sound waves that converge on a precise point in the brain. At the focal point, the ultrasound energy generates thermal or mechanical effects capable of destroying or modulating neural tissue.

When combined with real-time MRI guidance, clinicians can:

  • Accurately localize the target structure.

  • Monitor tissue temperature.

  • Ensure safety by avoiding damage to surrounding brain regions.

The technique has two main modes of action:

  1. Thermal ablation – Concentrated ultrasound energy heats the target area to around 55–60°C, causing irreversible tissue necrosis.

  2. Neuromodulation and blood–brain barrier opening – At lower intensities, ultrasound can temporarily alter neuronal activity or open the blood–brain barrier, allowing targeted drug delivery.

In Parkinson’s disease, focused ultrasound is primarily used for lesioning procedures in regions implicated in motor control.

2. Target Sites for Parkinson’s Disease

The choice of brain target depends on the predominant symptoms of the patient. The major targets include:

  • Thalamus (Ventral Intermediate Nucleus, VIM):

    • Primarily for patients with medication-resistant tremor.

    • Focused ultrasound thalamotomy can dramatically reduce tremor on the treated side.

  • Globus Pallidus Internus (GPi):

    • Suitable for reducing dyskinesias and improving overall motor function.

    • Focused ultrasound pallidotomy can decrease both tremor and rigidity.

  • Subthalamic Nucleus (STN):

    • A key target for DBS, also under investigation for focused ultrasound.

    • May improve multiple motor features, but safety and efficacy require further validation.

The ability to target different brain structures highlights the flexibility of MRgFUS in tailoring treatment to individual patient needs.

3. Clinical Indications

Focused ultrasound is currently considered for patients with:

  • Advanced Parkinson’s disease with disabling tremor or dyskinesias not adequately controlled by medication.

  • Unilateral symptoms that are more severe on one side.

  • Patients who are not candidates for deep brain stimulation (due to surgical risks, comorbidities, or patient preference for non-invasive approaches).

At present, most regulatory approvals (such as FDA clearance) are for unilateral thalamotomy in tremor-dominant PD. Clinical trials are ongoing for pallidotomy and subthalamotomy applications.

4. Procedure and Patient Experience

The MRgFUS procedure is typically performed as follows:

  1. Preparation: The patient’s head is immobilized in a stereotactic frame, and the scalp is shaved to ensure ultrasound transmission.

  2. Imaging: MRI scans are performed to identify the target structure.

  3. Energy delivery: Low-energy test sonications are applied to confirm the correct target and assess patient response.

  4. Thermal ablation: Once confirmed, higher energy is delivered to raise the temperature and ablate the tissue.

  5. Monitoring: Real-time MRI thermometry ensures safety and precision.

The entire procedure usually takes 3–4 hours and is performed under local anesthesia, allowing patients to provide feedback during targeting. Unlike open neurosurgery, there are no incisions, implants, or general anesthesia.

5. Efficacy of Focused Ultrasound in Parkinson’s Disease

Clinical studies have demonstrated promising results for MRgFUS in Parkinson’s disease:

  • Tremor reduction: Unilateral VIM thalamotomy results in significant improvement in tremor severity, often with immediate effects visible during the procedure.

  • Motor improvement: Pallidotomy studies show reduction in dyskinesias and improvement in rigidity and bradykinesia.

  • Sustained benefits: Many patients experience durable improvement for at least 1–2 years, though long-term data are still being collected.

  • Quality of life: Functional independence and daily activity performance improve significantly after treatment.

However, outcomes vary depending on the target and patient selection. Tremor-dominant patients tend to benefit the most, whereas complex motor fluctuations may require additional strategies.

6. Advantages of Focused Ultrasound

Focused ultrasound offers several distinct advantages over traditional surgical approaches:

  1. Non-invasive: No incisions, implants, or surgical wounds.

  2. Real-time feedback: MRI guidance and patient responsiveness ensure accurate targeting.

  3. Outpatient procedure: Most patients are discharged the same or next day.

  4. Rapid results: Tremor reduction is often visible immediately.

  5. Reduced surgical risks: No risk of infection or hardware-related complications as in DBS.

  6. Reversibility of test sonications: Low-intensity sonications allow testing before permanent lesioning.

These advantages make MRgFUS an appealing option, particularly for patients unwilling or unable to undergo invasive neurosurgery.

7. Limitations and Challenges

Despite its promise, focused ultrasound has several limitations:

  • Unilateral treatment only: Current approvals are for one side of the brain due to risk of speech and balance problems with bilateral lesioning.

  • Adverse effects: Possible side effects include numbness, imbalance, speech difficulties, and gait disturbances. Most are transient, but some may persist.

  • Restricted availability: The technology requires specialized equipment and expertise, limiting access to major medical centers.

  • Cost considerations: High equipment and procedure costs can be a barrier in many healthcare systems.

  • Limited long-term data: The durability of benefits beyond 3–5 years remains under investigation.

  • Not suitable for all symptoms: While effective for tremor, efficacy for bradykinesia, rigidity, and complex fluctuations is less robust compared to DBS.

These challenges underscore the need for careful patient selection and further research.

8. Comparison with Deep Brain Stimulation (DBS)

DBS remains the gold standard for advanced Parkinson’s disease. Comparing DBS and MRgFUS highlights key differences:

  • Invasiveness: DBS requires craniotomy and implantation of electrodes, while MRgFUS is non-invasive.

  • Adjustability: DBS stimulation parameters can be adjusted over time, whereas MRgFUS lesioning is permanent.

  • Targets: Both approaches can target the thalamus, GPi, or STN.

  • Side effects: DBS carries risks of infection, hardware malfunction, and battery replacement; MRgFUS avoids these but has risks of irreversible lesion-related side effects.

  • Symptom coverage: DBS is more effective for a broader range of symptoms, while MRgFUS is particularly beneficial for tremor.

Thus, MRgFUS is often considered an alternative for patients unsuitable for DBS.

9. Future Directions

The field of focused ultrasound is rapidly evolving, with several exciting future possibilities:

  1. Bilateral procedures: Research is exploring safe protocols for bilateral treatment to improve outcomes for both sides of the body.

  2. Neuromodulation (non-lesioning): Lower intensity focused ultrasound may allow reversible modulation of neural circuits without tissue destruction.

  3. Blood–brain barrier opening: Ultrasound combined with microbubbles can temporarily open the BBB, enabling targeted delivery of neuroprotective drugs or gene therapies.

  4. Expanded targets: Ongoing studies aim to refine targeting of the subthalamic nucleus and globus pallidus for broader symptom control.

  5. Integration with imaging biomarkers: Advanced imaging may improve precision and predict treatment response.

These innovations could expand the role of focused ultrasound from symptomatic treatment to potentially disease-modifying interventions.

10. Patient Perspectives and Quality of Life

Beyond clinical outcomes, patient-reported experiences highlight the transformative potential of MRgFUS. Many patients describe immediate relief from tremor, improved independence in daily tasks, and reduced reliance on caregivers. The absence of surgical wounds or implanted devices often reduces anxiety and improves acceptance.

However, realistic counseling is crucial—patients must understand that MRgFUS is not a cure, benefits may be unilateral, and some symptoms such as gait problems may persist. Shared decision-making between patients, caregivers, and clinicians ensures optimal treatment satisfaction.

Conclusion

Focused ultrasound represents a groundbreaking advancement in the treatment of Parkinson’s disease, combining precision, safety, and non-invasiveness. By allowing targeted ablation of key motor structures under MRI guidance, MRgFUS provides effective relief for medication-resistant tremor and motor complications, especially in patients unsuitable for deep brain stimulation.

While current applications are mainly unilateral thalamotomy, expanding evidence supports its potential in pallidotomy and subthalamotomy. Advantages such as rapid results, outpatient feasibility, and avoidance of hardware make MRgFUS an attractive option. Nevertheless, challenges including limited availability, cost, risk of side effects, and lack of long-term data must be addressed.

Looking forward, innovations in neuromodulation, blood–brain barrier opening, and bilateral treatment may significantly broaden its applications, positioning focused ultrasound as a central tool in both symptomatic and potentially disease-modifying therapies for Parkinson’s disease.

As research progresses, MRgFUS has the potential not only to reshape the management of Parkinson’s disease but also to transform the broader field of functional neurosurgery.

The Parkinson’s Protocol By Jodi Knapp Parkinson’s disease cannot be eliminated completely but its symptoms can be reduced, damages can be repaired and its progression can be delayed considerably by using various simple and natural things. In this eBook, a natural program to treat Parkinson’s disease is provided online. it includes 12 easy steps to repair your body and reduce the symptoms of this disease.

This eBook from Blue Heron Health News

Back in the spring of 2008, Christian Goodman put together a group of like-minded people – natural researchers who want to help humanity gain optimum health with the help of cures that nature has provided. He gathered people who already know much about natural medicine and setup blueheronhealthnews.com.

Today, Blue Heron Health News provides a variety of remedies for different kinds of illnesses. All of their remedies are natural and safe, so they can be used by anyone regardless of their health condition. Countless articles and eBooks are available on their website from Christian himself and other natural health enthusiasts, such as Julissa Clay , Shelly Manning , Jodi Knapp and Scott Davis.
Mr.Hotsia

I’m Mr.Hotsia, sharing 30 years of travel experiences with readers worldwide. This review is based on my personal journey and what I’ve learned along the way.I share my experiences on www.hotsia.com